These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 5612197)

  • 21. [Comparative study of specific blood activity in patients with fibrous-cavernous pulmonary tuberculosis during administration of different combinations of antibacterial preparations].
    Mkrtchian SV; Utkin VV; Egorkina ND
    Antibiotiki; 1970 Oct; 15(10):955-7. PubMed ID: 5487860
    [No Abstract]   [Full Text] [Related]  

  • 22. [Results of treatment of pulmonary tuberculosis in adults with second line drugs].
    Ropek M; Szymański A; Chetkowski A; Tarocińska B
    Gruzlica; 1968 Oct; 36(10):1043-6. PubMed ID: 5710086
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effectiveness of antibacterial therapy in patients with fibrocavernous tuberculosis inadequately treated in the past].
    Ianovskaia LM; Tarasova EF; Soldatov VE; Mikhaĭlova MM
    Probl Tuberk; 1969; 47(3):19-23. PubMed ID: 5354629
    [No Abstract]   [Full Text] [Related]  

  • 24. A comparison of ethionamide-cycloserine and ethionamide-pyrazinamide regimens in patients resistant to major chemotherapeutics.
    Vidinel I
    Scand J Respir Dis Suppl; 1970; 71():192-5. PubMed ID: 5271985
    [No Abstract]   [Full Text] [Related]  

  • 25. [Triple drug regimen with reserve drugs: ETA, PZA and CS in the treatment of chronic pulmonary tuberculosis].
    Wagner J
    Gruzlica; 1966 Mar; 34(3):249-54. PubMed ID: 5947778
    [No Abstract]   [Full Text] [Related]  

  • 26. [Methods of therapy of patients with chronic destructive pulmonary tuberculosis].
    Utkin VV; Rudoĭ NM
    Klin Med (Mosk); 1968 Dec; 46(12):36-43. PubMed ID: 5737381
    [No Abstract]   [Full Text] [Related]  

  • 27. [Protionamide tolerance in patients with pulmonary tuberculosis showing poor tolerance to ethionamide].
    Utkin VV; Zankisova IG; Poleshchuk AK; Krylova NP; Gridneva SM
    Vrach Delo; 1971 Nov; 11():79-81. PubMed ID: 5143287
    [No Abstract]   [Full Text] [Related]  

  • 28. [Treatment of tuberculosis in diabetics by preparations of the 2d series].
    Radanov R; Dobrev P
    Tuberkuloza; 1967; 19(5):666-7. PubMed ID: 5188403
    [No Abstract]   [Full Text] [Related]  

  • 29. [Experimental therapy with so-called "minor" tuberculostatics].
    Freerksen E
    Wien Med Wochenschr; 1966 Oct; 116(42):874-7. PubMed ID: 6005730
    [No Abstract]   [Full Text] [Related]  

  • 30. [Liver toxicity of aetina and pyracinamide and their control by determination of LAP activity in blood serum].
    Matzel W; Lindemann I
    Z Erkr Atmungsorgane Folia Bronchol; 1969; 131(1):87-98. PubMed ID: 5197904
    [No Abstract]   [Full Text] [Related]  

  • 31. [Effects of pyrazinamide on the liver in patients with tuberculosis. An ultrastructural study].
    Pilheu JA; de Salvo MC; Arias RF; Koch OR
    Medicina (B Aires); 1985; 45(1):15-9. PubMed ID: 3880102
    [No Abstract]   [Full Text] [Related]  

  • 32. [Late results of treatment of patients with drug resistant bacilli with ethionamide and other antitubercular agents].
    Pregowski W; Zagórecka A
    Gruzlica; 1968 Oct; 36(10):1047-9. PubMed ID: 5715457
    [No Abstract]   [Full Text] [Related]  

  • 33. [Possibilities and limitations of multiple chemoantibiotics in treatment of chronic pulmonary tuberculosis].
    Zanotelli F; Perusi O
    G Ital Mal Torace; 1966; 20(6):365-78. PubMed ID: 5997781
    [No Abstract]   [Full Text] [Related]  

  • 34. [Ethionamide in the treatment of patients infected with drug resistant bacilli].
    Pregowski W; Zagórecka A
    Pol Tyg Lek; 1966 May; 21(22):833-7. PubMed ID: 5962181
    [No Abstract]   [Full Text] [Related]  

  • 35. [Antituberculotics of the 2nd series in the surgery of pulmonary tuberculosis].
    Jancík E
    Z Tuberk Erkr Thoraxorg; 1965 Nov; 124(1):36-43. PubMed ID: 5899091
    [No Abstract]   [Full Text] [Related]  

  • 36. [Protionamide in the treatment of pulmonary tuberculosis].
    Kalabukha AV; Bialik IB; Mamolat AS
    Vrach Delo; 1972 May; 5():31-3. PubMed ID: 5029793
    [No Abstract]   [Full Text] [Related]  

  • 37. [Glutamic-oxalacetic and glutamic-pyruvic transaminases in tuberculosis of childhood].
    Boccitto C; Pocobelli A; Del Principe A; Zamparelli F
    Ann Ist Carlo Forlanini; 1965; 25(2):175-96. PubMed ID: 5294518
    [No Abstract]   [Full Text] [Related]  

  • 38. [Short-term treatment of tuberculosis with and without pyrazinamide in the second phase (TA-80)].
    Farga V; Valenzuela P; Yañez A; Valenzuela MT; Scheel G; Mendoza F; Torres E; Icekson I; Grinspun M; Fernández M
    Rev Med Chil; 1983 Jul; 111(7):750-4. PubMed ID: 6680460
    [No Abstract]   [Full Text] [Related]  

  • 39. [Combination of ethambutol with ethionamide, cycloserine and-or pyrazynamide in retreatment of pulmonary tuberculosis].
    Kekkaku; 1968 Feb; 43(2):91-5. PubMed ID: 5678013
    [No Abstract]   [Full Text] [Related]  

  • 40. [Tuberculostatic drugs of the second series. (Review of literature)].
    El'nik VI
    Klin Med (Mosk); 1966 Dec; 44(12):19-24. PubMed ID: 4302920
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.